Lack of neighborhood effects from a transcriptionally active phosphoglycerate kinase–neo cassette located between the murine β-major and β-minor globin genes
Open Access
- 1 July 2001
- journal article
- Published by American Society of Hematology in Blood
- Vol. 98 (1) , 65-73
- https://doi.org/10.1182/blood.v98.1.65
Abstract
For the treatment of β-globin gene defects, a homologous recombination-mediated gene correction approach would provide advantages over random integration-based gene therapy strategies. However, “neighborhood effects” from retained selectable marker genes in the targeted locus are among the key issues that must be taken into consideration for any attempt to use this strategy for gene correction. An Ala-to-Ile mutation was created in the β6 position of the mouse β-major globin gene (β6I) as a step toward the development of a murine model system that could serve as a platform for therapeutic gene correction studies. The marked β-major gene can be tracked at the level of DNA, RNA, and protein, allowing investigation of the impact of a retained phosphoglycerate kinase (PGK)-neo cassette located between the mutant β-major and β-minor globin genes on expression of these 2 neighboring genes. Although the PGK-neo cassette was expressed at high levels in adult erythroid cells, the abundance of the β6I mRNA was indistinguishable from that of the wild-type counterpart in bone marrow cells. Similarly, the output from the β-minor globin gene was also normal. Therefore, in this specific location, the retained, transcriptionally active PGK-neo cassette does not disrupt the regulated expression of the adult β-globin genes.Keywords
This publication has 38 references indexed in Scilit:
- Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globinNature, 2000
- Gene targeting is enhanced in human cells overexpressing hRAD51Gene Therapy, 1999
- Ribozyme-Mediated Repair of Sickle β-Globin mRNAs in Erythrocyte PrecursorsScience, 1998
- Human gene targeting by viral vectorsNature Genetics, 1998
- Correction of the Mutation Responsible for Sickle Cell Anemia by an RNA-DNA OligonucleotideScience, 1996
- Generation of a high-titer retroviral vector capable of expressing high levels of the human beta-globin gene.Proceedings of the National Academy of Sciences, 1995
- Retroviral vector sequences inhibit human β-globin gene expression in transgenic miceNucleic Acids Research, 1994
- Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells.Proceedings of the National Academy of Sciences, 1992
- Correction of a human beta S-globin gene by gene targeting.Proceedings of the National Academy of Sciences, 1991
- High-level beta-globin expression after retroviral transfer of locus activation region-containing human beta-globin gene derivatives into murine erythroleukemia cells.Proceedings of the National Academy of Sciences, 1990